NOMINEE AGREEMENT dated March 27, 2018 made by and among CYTOVIA INTERNATIONAL LLC and NOVENTIA PHARMA SRL regarding the the European market authorizations of Ceplene® and other products of CytoviaNominee Agreement • November 21st, 2018 • Immune Pharmaceuticals Inc • Pharmaceutical preparations
This nominee agreement ("Agreement") is as of the date mentioned on the first page but with retroactive effect as of January 1, 2018, (“Effective Date”) and entered into by and among:
